+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Search Bar & Filters

Found 24 Actively Recruiting clinical trials

S

Actively Recruiting

Researchers are investigating the frequency of Neuronal Ceroid Lipofusinosis Type 2 CLN2 in children aged 2 to 6 years who have nonspecific neurological symptoms such as idiopathic seizures, speech disorders, and motor dysfunctions. This multicenter, non-drug screening study focuses on children without hypoxic ischemic encephalopathy, head trauma, or developmental brain anomalies, aiming to better understand the demographic and clinical features of those with possible CLN2 disease. Children first undergo assessments including recording demographic and medical history, seizure frequency, cognitive and language development evaluations, physical exams assessing muscle strength, gait, and coordination, as well as neurological evaluations using EEG and MRI scans. Those showing specific signs like speech disorder with seizures, movement problems, particular EEG responses, or MRI findings will have blood samples taken to measure Tripeptidyl Peptidase 1 enzyme levels. If enzyme activity is low, genetic testing is performed to investigate CLN2 disease. Participants are involved for up to one year during which various clinical, neurological, and imaging evaluations are done. Blood samples are collected for enzyme and genetic analyses. The main outcome measured is the frequency of CLN2 disease in this group. The study tracks each childs symptoms, neurological findings, and imaging results to better identify and understand CLN2 in children with these symptoms.

Age: 2Years - 6YearsAll Genders
34 locations
S

Actively Recruiting

Researchers are evaluating zolbetuximab combined with pembrolizumab and chemotherapy in adults with stomach cancer or gastroesophageal junction GEJ cancer that is HER2-negative, Claudin 18.2-positive, and PD-L1-positive. The study focuses on people with locally advanced unresectable or metastatic disease who may have had prior standard treatments. This phase 3 randomized, double-blind study aims to understand how well zolbetuximab works with other therapies compared to placebo with pembrolizumab and chemotherapy. Participants receive either zolbetuximab or placebo intravenously every 2 or 3 weeks, along with pembrolizumab infusions every 3 or 6 weeks. Chemotherapy is given as either CAPOX oral capecitabine tablets and oxaliplatin infusions or mFOLFOX6 infusions of oxaliplatin, folinic acid, and 5-fluorouracil over several cycles. Treatment continues until cancer progression, intolerable side effects, or another cancer therapy is needed. Pembrolizumab may be given for up to 2 years. During the study, participants visit clinics for treatment infusions, health checks, and scans to monitor cancer changes. Medical problems and side effects are tracked, and tumor samples may be collected if treatment stops due to progression. Follow-up visits and telephone health checks continue after treatment to monitor participants health and cancer status. The study measures overall survival as the main outcome over up to 72 months.

Age: 18Years +All GendersPhase 3
252 locations
C

Actively Recruiting

Researchers are comparing two types of nerve blocks to manage pain after knee arthroscopy, a common orthopedic surgery. The study focuses on the anterior nerves of the knee ANK block and the femoral nerve block, both guided by ultrasound. The goal is to assess their effects on pain relief, pain scores, intraoperative heart rate and blood pressure, and the time it takes patients to start moving again after surgery. Adult patients aged 18 to 65 undergoing elective knee arthroscopy under spinal anesthesia will be randomly assigned to receive either an ultrasound-guided ANK block or a femoral nerve block before surgery. Both blocks use 20 mL of 0.25% bupivacaine. After the nerve block, patients receive spinal anesthesia. Heart rate and blood pressure are monitored throughout surgery. Postoperative pain is managed with intravenous paracetamol and tramadol as needed, with pain levels checked at multiple times up to 24 hours after surgery. Participants will have their sensory and motor block assessed 20 minutes after the nerve block. Pain scores at rest and with movement are recorded at 0, 2, 4, 6, 12, and 24 hours post-surgery. Researchers also track tramadol and paracetamol use, time to first rescue pain medication, quadriceps muscle strength, time to first mobilization within 48 hours, and any complications from the nerve blocks. The study lasts through surgery and the 24 to 48 hours following, with careful monitoring of analgesic effectiveness and safety.

Age: 18Years - 65YearsAll GendersPhase Not Applicable
1 location
S

Actively Recruiting

Researchers are evaluating whether using a wider surgical tape mesh in transobturator tape TOT surgery improves outcomes for women with stress urinary incontinence SUI. This randomized controlled trial compares a 1.2 cm wide mesh new method to the standard 1.0 cm mesh. The study aims to determine if the wider mesh improves urinary control and reduces complications, with participants followed for one year. Participants will be randomly assigned to receive TOT surgery using either the 1.2 cm or 1.0 cm monofilament polypropylene mesh. All surgeries will be performed by one experienced surgeon using the same surgical technique, anesthesia, and care protocols to ensure consistency. Follow-up visits are planned at 1 week, 1 month, and 1 year after surgery, with evaluations by a blinded assessor. During the study, participants will have their urinary leakage tested and complete symptom questionnaires. Researchers will measure the primary outcome of objective cure through a negative stress test at 6 months. Secondary outcomes include symptom improvement, mesh-related complications like erosion or infection, recurrence of urinary incontinence, and patient satisfaction. The goal is to see if the modified mesh provides better support and fewer issues than the standard mesh.

Age: 18Years +FEMALEPhase Not Applicable
1 location
S

Actively Recruiting

Researchers are evaluating whether taking an oral laxative before elective laparoscopic colorectal surgery affects the small-bowel diameter and the difficulty of the surgery. This study involves adult patients scheduled for laparoscopic colorectal resection and compares the effects of preoperative bowel preparation methods. The pilot study aims to provide early evidence that may inform future research and improve bowel-preparation practices. Participants will be randomly assigned to one of two groups one group will receive an oral laxative plus a rectal enema before surgery, while the other group will receive only a rectal enema. During surgery, measurements of the jejunum and ileum diameters will be taken using a standardized method. Surgeons will also evaluate operative difficulty and record various intraoperative and postoperative outcomes. Participants will undergo surgery with these preparations and have their bowel diameters measured intraoperatively. Researchers will assess surgical difficulty, blood loss, any complications, operation time, and postoperative events within 30 days. This study includes assessments during and immediately after surgery, with follow-up on complications up to a month later. The study is expected to last approximately one year from start to completion.

Age: 18Years +All GendersPhase Not Applicable
1 location
S

Actively Recruiting

Researchers are evaluating the effects of Quran recital on fatigue and mental well-being in patients with multiple sclerosis. The study aims to test whether listening to Quran recitation can reduce fatigue and improve mental well-being in those living with this condition. This randomized controlled trial involves 50 patients who meet the inclusion criteria and voluntarily agree to participate. Participants will be randomly assigned to either the Quran recital group or a control group. The Quran recital group will listen to Surah Yasin from the Quran for 30 minutes using an mp3 player, three times a week Monday, Wednesday, and Friday between 900 PM and 1000 PM, continuing this practice for 4 weeks. The control group will continue their usual treatment and care without any additional intervention. During the study, patients personal and contact information will be collected, and pre-test forms will be completed. Researchers will call participants in the Quran recital group to check if they continue the practice. Final assessments will be conducted in person at the hospital at the end of the 4th week. The primary outcome measured is the impact of fatigue, with secondary outcomes including fatigue severity and mental well-being assessed after one month.

Age: 18Years - 80YearsAll GendersPhase Not Applicable
1 location
S

Actively Recruiting

This research aims to understand how blood pressure levels affect the development of bedsores pressure ulcers in adults hospitalized in an internal medicine intensive care unit. The study focuses on critically ill patients who face increased risk of bedsores due to factors like prolonged immobility, reduced consciousness, circulatory problems, and unstable blood circulation. It specifically investigates how changes in systemic blood pressure, such as low or high blood pressure, impact skin health and contribute to bedsore formation. Participants are adult intensive care patients aged 18 to 70 who are bedridden and immobile. The study involves observing these patients over a period of 10 days, during which the occurrence and timing of bedsores will be carefully recorded. Vital signs including blood pressure systolic and diastolic, heart rate, and respiratory rate will be monitored regularly to assess their relationship with bedsore development. During the study, participants vital signs will be tracked daily alongside the monitoring of skin condition to detect bedsores. Researchers will use these observations to measure the primary outcome of bedsore occurrence over 10 days. The study also collects secondary data on blood pressure, heart rate, and respiratory rate over the same period. The total participation duration is 10 days, covering continuous monitoring while patients remain in intensive care.

Age: 18Years - 70YearsAll Genders
1 location
Q

Actively Recruiting

Hemophilia A is a hereditary bleeding disorder that causes repeated bleeding episodes, especially in joints and muscles, leading to chronic musculoskeletal problems and joint damage known as hemophilic arthropathy. This condition results in ongoing pain, reduced mobility, and difficulties with daily activities. While advances in preventive treatments have improved life expectancy, long-term joint complications continue to affect quality of life QoL in adults. This research aims to better understand the factors influencing QoL in adults with severe hemophilia A. The study evaluates joint health, pain severity, dynamic balance, and fall history in 36 adults with severe hemophilia A, aged 18 to 65 years. Joint health is measured using the Hemophilia Joint Health Score HJHS, focusing on knees and ankles. Dynamic balance is assessed with a computerized stabilometric platform through the Limits of Stability test. Pain levels are recorded using a numeric rating scale, and participants report the number of falls they experienced in the past year. These combined factors are studied to explore their relationship with QoL. Participants undergo assessments that include clinician-administered joint exams, balance testing, pain evaluations, and questionnaires about falls and quality of life using a hemophilia-specific tool. The study measures baseline health-related QoL, joint health, and postural balance, along with musculoskeletal pain and fall history. The findings aim to highlight key aspects affecting well-being and identify possible targets for rehabilitation to improve daily functioning in adults with hemophilia.

Age: 18Years - 65YearsMALE
1 location
S

Actively Recruiting

Researchers are conducting an observational study to screen adults aged 18 and over who visit hospital outpatient clinics in Turkey for malnutrition and sarcopenia risks. The study focuses on patients attending oncology, neurology, and geriatric clinics to better understand these conditions across diverse patient groups. This non-interventional, cross-sectional design means participants are observed without receiving experimental treatments. Participants are screened once during their outpatient visit without any study treatments or interventions. The study collects information on malnutrition risk, sarcopenia risk, body mass index, calf circumference, hand grip strength, biochemical parameters, healthcare use, and nutrition treatments. Data is gathered on the screening day only. During the study visit, researchers will assess physical and biochemical measures to evaluate nutrition and muscle health. Participants provide informed consent before any assessments. The study measures malnutrition and sarcopenia risks as primary outcomes on the first day and includes several secondary measures related to body composition and healthcare use. The study will continue enrolling participants until April 2027.

Age: 18Years +All Genders
69 locations
S

Actively Recruiting

Healthy Volunteer

Researchers are investigating how pressures from the tongue, lips, and cheeks affect the development of a narrow upper jaw, known as maxillary constriction. This study aims to understand if different muscle pressure patterns contribute to this condition and how that knowledge might improve orthodontic treatment outcomes. It is a randomized clinical study involving patients aged 12 to 25 with skeletal Class I jaw alignment. Participants are divided into two groups those with a narrow upper jaw and those with normal jaw width. Using a device called the Iowa Oral Performance Instrument IOPI, researchers measure the strength and endurance of the tongue, lips, and cheeks by having participants press a small air-filled bulb in their mouths. These measurements are taken before any orthodontic treatment begins, including maximum tongue pressure and lip and cheek pressures, to compare muscle function between the groups. During the study, participants will undergo a series of pressure tests using the IOPI device, performed three times each with rest intervals. Researchers will assess muscle pressures in kilopascals and analyze the data to explore relationships between muscle forces and jaw width. The primary measurement is the maximum voluntary tongue pressure taken at baseline. This study involves no treatment interventions and focuses on diagnostic assessments to better understand the role of oral muscles in jaw development.

Age: 12Years - 25YearsAll GendersPhase Not Applicable
1 location

1-10 of 24

1